Spanish Research Group on Breast Cancer (GEICAM)
Grupo Español de Investigación en Cáncer de Mama (GEICAM)
Spain
1 December 2017 - 30 November 2018
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Spanish Research Group on Breast Cancer (GEICAM) published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Spanish Research Group on Breast Cancer (GEICAM) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 1 | 0.07 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 1 | 0.07 | |
Top articles by Altmetric score in current window
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Nature Communications
2018-07-24
1 December 2017 - 30 November 2018
International vs. domestic collaboration by FC
- 23.95% Domestic
- 76.05% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by FC (7 total)
- Spanish Research Group on Breast Cancer (GEICAM), Spain
- Domestic institution
-
Autonomous University of Madrid (UAM), Spain
(0.10)
-
Hospital Universitario Virgen de la Victoria, Spain
(0.10)
-
Virgen del Rocío University Hospital, Spain
(0.10)
-
Institute of Health Carlos III (ISCIII), Spain
(0.09)
-
Investigación Sanitaria del Hospital Gregorio Marañón (IISGM), Spain
(0.09)
-
Complutense University of Madrid (UCM), Spain
(0.08)
-
Charles III University of Madrid (UC3M), Spain
(0.07)
Top 10 international collaborators by FC (14 total)
- Spanish Research Group on Breast Cancer (GEICAM), Spain
- Foreign institution
-
Garvan Institute of Medical Research, Australia
(0.42)
-
The Kinghorn Cancer Centre (TKCC), Australia
(0.30)
-
St Vincent's Health Australia, Australia
(0.20)
-
University of New South Wales (UNSW), Australia
(0.18)
-
University of Bristol (UoB), United Kingdom (UK)
(0.10)
-
Centre for Cancer Biology, Australia
(0.10)
-
The University of Adelaide (Adelaide Uni), Australia
(0.10)
-
Rajiv Gandhi Centre for Biotechnology (RGCB), India
(0.10)
-
The University of Sydney (USYD), Australia
(0.09)
-
Queensland Health, Australia
(0.09)
Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.
Participating institutions
Spanish Research Group on Breast Cancer (GEICAM) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Translational Research In Oncology (TRIO), Canada
- Breast International Group (BIG), Belgium
- National Surgical Adjuvant Breast and Bowel Project (NSABP), United States of America (USA)
- The University of Texas MD Anderson Cancer Center, United States of America (USA)
- UNC Lineberger Comprehensive Cancer Center, United States of America (USA)
- Fondazione Michelangelo, Italy
- Canadian Cancer Trials Group (CTG), Queen's University, Canada
- Latin American Cooperative Oncology Group (LACOG), Brazil
- GBG Forschungs GmbH, Germany
- Cancer Trials Ireland, Ireland
- SWOG, United States of America (USA)
- Central European Cooperative Oncology Group (CECOG), Austria
- ECOG-ACRIN Cancer Research Group, United States of America (USA)
- International Breast Cancer Study Group (IBCSG), Switzerland
- Austrian Breast and Colorectal Cancer Study Group (ABCSG), Austria
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
